O'Brien P Q, Schröder R, Johnson M A. "Method for the Synthesis of 3-(4-Hydroxypiperidin-1-yl)-1-methylpyrazin-2(1H)-one" [P]. US Patent, US 11551196 B2, 2023-03-09.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2017, 2265, (1), 2379-2389.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2012, 877, 6976-6982.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 3-(4-Hydroxypiperidin-1-yl)-1-methylpyrazin-2(1H)-one Using HRMS and NMR". Molecules, 2022, 1534, (11), 3174-3192.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2024, 609, (4), 9474-9493.